| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Nuvalent, Inc. (NUVL) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 27 sells. NUVL is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 1.38M | $170.65M | - | |
| CEO | 324.9K | $40.10M | - | |
| CFO | 99.2K | $12.25M | - | |
| Other | 86.8K | $10.72M | -5,500 | |
| Other | 83.4K | $10.29M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 6, 2025 | Balcom Alexandra51 | Chief Financial Officer | Sell | 4,016 | $79.68 | $320,009.01 | -2.1% | -17.2% | +24.5% | |
| Jan 6, 2025 | Porter James Richard47 | President And CEO | Sell | 17,301 | $79.68 | $1,378,603.83 | -2.2% | -17.2% | +24.5% | |
| Dec 23, 2024 | Shair Matthew45 | Director | Sell | 2,000 | $83.78 | $167,565.05 | -0.5% | -8.0% | +25.0% | |
| Dec 16, 2024 | Porter James Richard47 | President And CEO | Sale+OE | 27,000 | $86.61 | $2,338,435.50 | -6.6% | -11.9% | +17.4% | |
| Dec 11, 2024 | Hack Andrew A. F.62 | Director | Sell | 1,250,000 | $88.00 | $110,000,000.00 | -46.3% | -25.0% | +13.1% | |
| Nov 29, 2024 | Balcom Alexandra51 | Chief Financial Officer | Sale+OE | 10,000 | $95.79 | $957,940.48 | -12.7% | -22.5% | +13.1% | |
| Nov 25, 2024 | Shair Matthew45 | Director | Sell | 2,000 | $96.22 | $192,442.86 | -0.3% | -18.4% | +14.9% | |
| Nov 15, 2024 | Porter James Richard47 | President And CEO | Sale+OE | 27,000 | $87.94 | $2,374,478.68 | -3.4% | -6.8% | +11.1% | |
| Nov 1, 2024 | Noci Darlene | Chief Development Officer | Sale+OE | 5,000 | $88.60 | $442,980.40 | -4.6% | -1.6% | +11.3% | |
| Oct 31, 2024 | Balcom Alexandra51 | Chief Financial Officer | Sale+OE | 10,000 | $89.19 | $891,879.40 | -6.5% | -3.4% | +12.2% |